SCHEMBL13360439

SCHEMBL13360439

CCc1cc(C)cc(OC)c1C1C(=O)NC2(CCC(OC)CC2)C1O

nearest known ligand 0.32

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
BACE1 P56817 3/20 0.31
CNR2 P34972 1/20 0.31
GRM1 Q13255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CDK4 P11802 1/20 0.30
CCND1 P24385 1/20 0.30
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2996875 0.78 CNR2 (0.31) MEN1KMT2ATDP1CNR2CDK4
SCHEMBL3076232 0.71 ACACB (0.32) BACE1GRM1
SCHEMBL12238052 0.71 ACACB (0.31)
SCHEMBL13070822 0.70 ACACB (0.48) BACE1GRM1CDK4CCND1GSK3B
SCHEMBL2888125 0.70 ACACB (0.34) KMT2ABACE1GRM1
SCHEMBL2886584 0.69 ACACB (0.33) KMT2ABACE1
SCHEMBL3001186 0.68 KMT2A (0.36) MEN1KMT2AALDH1A1
SCHEMBL5435809 0.67 BACE1 (0.32) BACE1
SCHEMBL13071070 0.67 ACACB (0.38)
SCHEMBL13070820 0.66 ACACB (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718186-B2 2-alkoxy-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives BAYER CROPSCIENCE AG (DE) 2010-05-18 US disclosed
US-20080220973-A1 2-Alkoxy-6-Alkyl-Phenyl-Substituted Spirocyclic Tetramic Acid Derivatives BAYER CROPSCIENCE AG (DE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080220973-A1 2-Alkoxy-6-Alkyl-Phenyl-Substituted Spirocyclic Tetramic Acid Derivatives DDT, PAOX, PTPRG MEN1 4769/4885KMT2A 1494/4885TDP1 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.